Armata Pharmaceuticals, Inc.
ARMP · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$26,675 | -$16,295 | -$6,531 | $2,600 |
| Dep. & Amort. | $370 | $366 | $377 | $380 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $575 | $781 | $354 |
| Change in WC | $1,814 | -$1,996 | -$1,197 | $1,189 |
| Other Non-Cash | $20,193 | $10,139 | -$1,010 | -$12,450 |
| Operating Cash Flow | -$4,298 | -$7,211 | -$7,580 | -$7,927 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$242 | -$149 | -$99 | $77 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$242 | -$149 | -$99 | $77 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $15,000 | $0 | $10,000 | -$34,889 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$14 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$32 | $0 | $0 | $34,889 |
| Financing Cash Flow | $14,968 | $0 | $9,986 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $10,428 | -$7,360 | $2,307 | -$7,850 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,328 | $17,078 | $14,771 | $22,621 |
| End Cash | $14,756 | $9,718 | $17,078 | $14,771 |
| Free Cash Flow | -$4,540 | -$7,360 | -$7,679 | -$7,850 |